Edition:
India

Vanda Pharmaceuticals Inc (VNDA.OQ)

VNDA.OQ on NASDAQ Stock Exchange Global Market

14.95USD
1:30am IST
Change (% chg)

$0.10 (+0.67%)
Prev Close
$14.85
Open
$14.80
Day's High
$14.95
Day's Low
$14.52
Volume
68,412
Avg. Vol
166,317
52-wk High
$20.35
52-wk Low
$11.90

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 44.28 -0.041
Sep '17 41.34 -0.101
Jun '17 42.06 -0.034
Mar '17 37.42 -0.172
FY 2016 Dec '16 38.24 -0.014
Sep '16 38.48 -0.010
Jun '16 36.03 -0.107
Mar '16 33.26 -0.287
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 46.14 49.00 39.40 49.05
Quarter Ending Sep-18 5 48.16 51.20 41.10 50.95
Year Ending Dec-18 6 187.35 195.30 158.00 202.46
Year Ending Dec-19 4 243.95 262.80 223.00 251.26
Earnings (per share)
Quarter Ending Jun-18 4 -0.08 0.02 -0.19 -0.05
Quarter Ending Sep-18 4 -0.17 0.05 -0.57 0.04
Year Ending Dec-18 5 -0.40 0.04 -0.83 -0.45
Year Ending Dec-19 3 0.58 0.77 0.23 0.65
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 32.83 62.74 36.10
EPS (TTM) % 56.07 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Vanda Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.00 -3.45 80 --
13 Week 3.27 -1.76 99 --
26 Week 26.18 16.59 99 --
52 Week 3.09 -12.62 99 --
YTD 8.78 -4.47 99 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 80.75%
# of Holders: 184
Total Shares Held: 41,393,226
3 Mo. Net Change: 64,920
# New Positions: 4
# Closed Positions: 2
# Increased Positions: 8
# Reduced Positions: 14
# Net Buyers: -6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.